Our drugs engage the immune system to fight tumors
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
What they do:
Adventris makes cancer vaccines
Quick facts:
HQ: Baltimore, MD, United States
What they do:
Breakthrough medicines unlocking the biology of heme
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Targeting the Tumor Ecosystem to address cancer drug resistance.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026
What they do:
Using CRISPR to find treatments for cancer and inflammation
Quick facts:
HQ: San Francisco, CA, United States
Our drugs engage the immune system to fight tumors
Salt Lake City, UT, United States
2 employees, according to the company profile.
There are no funding rounds for Eris Biotech in our data.
Similar startups: Adventris Pharmaceuticals, Velorum Therapeutics, and Alixia.